Lori Weinberg, MD
Gynecologic Oncology · Coon Rapids, MNNPI 1326204942
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $32,617 of the $47,381 with a category attached, or 68.8%. AbbVie accounts for 63.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $29,513 and has fallen 69.6% since, to $8,977 in 2025. Among gynecologic oncology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $1101.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$30K
- Immunogen, Inc.$15K
- AstraZeneca$2K
- Merck$16
- Seagen Inc.$16
What the payments were for
- Consulting fees$11,03123%
- Speaking & faculty fees$32,61769%
- Grants$1200%
- Travel & lodging$2,9316%
- Food & beverage$6821%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $30,214 |
| Immunogen, Inc. | 11 | $15,025 |
| AstraZeneca | 3 | $2,110 |
| Merck | 1 | $16 |
| Seagen Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Elahere$44,713
- NATRELLE SALINE-FILLED BREAST IMPLANTS$120
- REVOLVE$120
How this compares
$47,381 in reported general payments places this provider in the 90th percentile of 39 gynecologic oncology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 18 | $11,546 |
| EliquisApixaban | 12 | $6,530 |
| Megestrol Acetate | 20 | $794 |
| Dexamethasone | 22 | $347 |
| Letrozole | 25 | $263 |
| Ondansetron Hcl | 24 | $159 |
| Prochlorperazine Maleate | 11 | $142 |
| Gabapentin | 17 | $108 |
| Clobetasol Propionate | 17 | $87 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Coon Rapids
- Nicole SpencerCoon Rapids$643
- Annie TanCoon Rapids$295
- Levi DownsSt Louis Park$108K
- Jamie Bakkum-GamezRochester$51K
- Ebrahim VersiEden Prairie$32K
- Britt EricksonMinneapolis$28K
- William ClibyRochester$15K
- Melissa GellerMinneapolis$14K
- Emily PrendergastMinneapolis$10K
- Carrie LangstraatRochester$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.